Chinese Biotech Company To Mass Produce Ebola Vaccine Being Developed By Country’s Military

Reuters: Chinese firm says plans to ‘mass produce’ Ebola vaccine
“A Chinese firm plans to mass produce a military-developed vaccine against Ebola, even as the epidemic which killed more than 11,000 people in West Africa beings to fade…” (Jourdan, 10/14).

Xinhua News: China to mass produce Ebola vaccine
“…Tianjin CanSino Biotechnology Inc. has started construction of an industry base to produce the vaccine in the Tianjin Economic and Technological Development Area, sources with the company said on Wednesday. Investment into the base totals two billion yuan (about 317 million U.S. dollars) and construction will be complete in September, 2018. The base also produces other vaccines against pneumonia, meningitis, and tuberculosis. Annual production is around 200 million vaccines…” (10/14).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.